Goldman Sachs’s Calithera Biosciences, Inc CALA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q2
Sell
-6,187
Closed -$50K 5994
2022
Q1
$50K Buy
6,187
+3,643
+143% +$29.4K ﹤0.01% 5474
2021
Q4
$34K Sell
2,544
-951
-27% -$12.7K ﹤0.01% 5405
2021
Q3
$152K Sell
3,495
-6,670
-66% -$290K ﹤0.01% 4960
2021
Q2
$425K Sell
10,165
-5,515
-35% -$231K ﹤0.01% 4510
2021
Q1
$759K Buy
15,680
+9,167
+141% +$444K ﹤0.01% 4099
2020
Q4
$639K Sell
6,513
-1,090
-14% -$107K ﹤0.01% 3692
2020
Q3
$525K Sell
7,603
-186
-2% -$12.8K ﹤0.01% 3646
2020
Q2
$823K Buy
7,789
+1,971
+34% +$208K ﹤0.01% 3338
2020
Q1
$517K Sell
5,818
-961
-14% -$85.4K ﹤0.01% 3479
2019
Q4
$774K Buy
6,779
+958
+16% +$109K ﹤0.01% 3452
2019
Q3
$360K Sell
5,821
-3,089
-35% -$191K ﹤0.01% 3722
2019
Q2
$695K Buy
8,910
+2,173
+32% +$169K ﹤0.01% 3383
2019
Q1
$908K Buy
6,737
+15
+0.2% +$2.02K ﹤0.01% 3309
2018
Q4
$539K Buy
6,722
+2,652
+65% +$213K ﹤0.01% 3386
2018
Q3
$427K Sell
4,070
-1,473
-27% -$155K ﹤0.01% 3511
2018
Q2
$554K Sell
5,543
-3,893
-41% -$389K ﹤0.01% 3479
2018
Q1
$1.19M Buy
9,436
+1,068
+13% +$135K ﹤0.01% 3116
2017
Q4
$1.4M Buy
8,368
+1,443
+21% +$241K ﹤0.01% 3002
2017
Q3
$2.18M Buy
6,925
+466
+7% +$147K ﹤0.01% 2829
2017
Q2
$1.92M Sell
6,459
-240
-4% -$71.3K ﹤0.01% 2829
2017
Q1
$1.55M Buy
6,699
+5,892
+730% +$1.36M ﹤0.01% 2892
2016
Q4
$52K Buy
807
+258
+47% +$16.6K ﹤0.01% 4228
2016
Q3
$36K Sell
549
-674
-55% -$44.2K ﹤0.01% 4360
2016
Q2
$91K Buy
+1,223
New +$91K ﹤0.01% 4153
2015
Q3
Sell
-1,179
Closed -$168K 4742
2015
Q2
$168K Buy
+1,179
New +$168K ﹤0.01% 4101